Drugs Safety Labeling Updates
Drugs Safety Labeling Updates
| Scientific Name | Trade Name | Updated Section | Safety-Related Labeling Changes | Date |
|---|---|---|---|---|
| Hydrochlorothiazide, Telmisartan | Micardis Plus | 4.4 Special Warnings and Special Precautions for Use 4.8 Undesirable effects | Acute respiratory distress syndrome (ARDS) | Sep,2022 |
| Hydrochlorothiazide, Eprosartan | Teveten Plus | 4.4 Special Warnings and Special Precautions for Use 4.8 Undesirable effects | Acute respiratory distress syndrome (ARDS) | Sep,2022 |
| Hydrochlorothiazide, Amlodipine, Valsartan | Exforge Hct | 4.4 Special Warnings and Special Precautions for Use 4.8 Undesirable effects | Acute respiratory distress syndrome (ARDS) | Sep,2022 |
| Hydrochlorothiazide, Losartan | Hyzaar | 4.4 Special Warnings and Special Precautions for Use 4.8 Undesirable effects | Acute respiratory distress syndrome (ARDS) | Sep,2022 |
| Hydrochlorothiazide, Candesartan | Atacand Plus | 4.4 Special Warnings and Special Precautions for Use 4.8 Undesirable effects | Acute respiratory distress syndrome (ARDS) | Sep,2022 |
| Hydrochlorothiazide, Bisoprolol | Concor Plus | 4.4 Special Warnings and Special Precautions for Use 4.8 Undesirable effects | Acute respiratory distress syndrome (ARDS) | Sep,2022 |